ArticleJournal of clinical immunology2018

Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.

Markéta Bloomfield et al.PubMed ↗Publisher ↗

No numbers read from the abstract.